Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “a Randomized Double-blind Study”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT02119676
What this trial is testing

Study of Ruxolitinib in Colorectal Cancer Patients

Who this might be right for
CRC (Colorectal Cancer)
Incyte Corporation 396
Large-scale testing (Phase 3)WithdrawnNCT02955368
What this trial is testing

Clinical Trial to Evaluate the Efficacy and Safety of DP-R212

Who this might be right for
HypertensionHypercholesterolemia
Alvogen Korea
Testing effectiveness (Phase 2)Study completedNCT03823391
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of ABBV-3373 in Participants With Moderate to Severe Rheumatoid Arthritis (RA)

Who this might be right for
Rheumatoid Arthritis (RA)
AbbVie 48
Large-scale testing (Phase 3)Study completedNCT02466997
What this trial is testing

Efficacy of Tacrolimus in Adults With Facial Non-segmental Vitiligo - VITAC

Who this might be right for
Vitiligo
University Hospital, Bordeaux 42
Testing effectiveness (Phase 2)Study completedNCT04830397
What this trial is testing

Study to Evaluate QLS-101 Compared to Timolol Maleate Eye Drops in Subjects With High Eye Pressure (Glaucoma or Ocular Hypertension).

Who this might be right for
Primary Open Angle GlaucomaOcular Hypertension
Qlaris Bio, Inc. 84
Testing effectiveness (Phase 2)Study completedNCT05198310
What this trial is testing

Study to Assess the Safety, Pharmacokinetics, and Efficacy of KPL-404 in Participants With Rheumatoid Arthritis With Inadequate Response or Intolerance to at Least One Biologic Disease-modifying Anti-rheumatic Drug or a Janus Kinase Inhibitor

Who this might be right for
Arthritis, Rheumatoid
Kiniksa Pharmaceuticals, Ltd. 145
Early research (Phase 1)Study completedNCT01827982
What this trial is testing

Investigate the Safety, Tolerability and Pharmacokinetics of JNJ-54861911 in Healthy Volunteers Compared With Placebo

Who this might be right for
Healthy
Janssen Research & Development, LLC 56
Large-scale testing (Phase 3)Study completedNCT00144482
What this trial is testing

Recombinant Human Erythropoietin in Anemic Cancer Patients Undergoing Chemotherapy

Who this might be right for
Chemotherapy Induced Anemia
Chugai Pharmaceutical 122
Large-scale testing (Phase 3)Study completedNCT04708782
What this trial is testing

Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary FibrosisInterstitial Lung Disease
United Therapeutics 598
Post-approval studies (Phase 4)Study completedNCT03098823
What this trial is testing

A Crossover Study to Compare RAYOS to IR Prednisone to Improve Fatigue and Morning Symptoms for SLE

Who this might be right for
Lupus Erythematosus, SystemicLupus ErythematosusFatigue
Ampel BioSolutions, LLC 62
Testing effectiveness (Phase 2)UnknownNCT03669718
What this trial is testing

Phase 2 Study of Cemiplimab ± ISA101b in HPV16-Positive OPC

Who this might be right for
Squamous Cell Carcinoma of the OropharynxHPV16 Positive
ISA Pharmaceuticals 194
Not applicableEnded earlyNCT02239510
What this trial is testing

Efficacy of Linaclotide to Senna for CIC

Who this might be right for
Chronic Idiopathic Constipation
TriHealth Inc. 9
Large-scale testing (Phase 3)Study completedNCT04633213
What this trial is testing

A Study Evaluating HBM9036 Efficacy and Safety on Moderate to Severe Dry Eye

Who this might be right for
Dry Eye
Harbour BioMed (Guangzhou) Co. Ltd. 577
Early research (Phase 1)Study completedNCT06086613
What this trial is testing

A First-in-Human Study Evaluating AGA2115 in Adult Healthy Volunteers

Who this might be right for
Osteogenesis Imperfecta
Angitia Incorporated Limited 72
Testing effectiveness (Phase 2)Study completedNCT04840823
What this trial is testing

Enoxacin for Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
McGill University 8
Not applicableUnknownNCT04231123
What this trial is testing

Pericapsular Nerve Group Block for Elective Hip Arthroplasty

Who this might be right for
Postoperative Pain
Centre Hospitalier Universitaire de Tivoli 60
Large-scale testing (Phase 3)Study completedNCT01638923
What this trial is testing

Study of a 4-phasic Oral Contraceptive for the Treatment of Heavy Menstrual Bleeding

Who this might be right for
Metrorrhagia
Bayer 339
Early research (Phase 1)Ended earlyNCT02566759
What this trial is testing

A TAK-831-1001, Single and Multiple Rising Dose Study in Healthy Participants

Who this might be right for
Schizophrenia, Cerebellar Ataxia
Neurocrine Biosciences 110
Testing effectiveness (Phase 2)Study completedNCT03265288
What this trial is testing

Study of LAU-7b in the Treatment of Cystic Fibrosis in Adults

Who this might be right for
Cystic Fibrosis
Laurent Pharmaceuticals Inc. 166
Early research (Phase 1)Active Not RecruitingNCT07095049
What this trial is testing

Safety, Tolerability, and Systemic Exposure of Apo-Si- K170A-C76 in Healthy Volunteers

Who this might be right for
SARS-CoV-2 (COVID-19) Infection
Interna Therapeutics Ltd. 56
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation